Company registration number 05211098 (England and Wales)
DR KERSHAW'S HOSPICE (TRADING) LIMITED
ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024
DR KERSHAW'S HOSPICE (TRADING) LIMITED
COMPANY INFORMATION
Directors
Dr P Cook
J R Lipton
(Appointed 1 September 2023)
Secretary
R Damianou
Company number
05211098
Registered office
Turf Lane
Royton
Oldham
Lancashire
OL2 6EU
Accountants
Chadwicks
Chartered Accountants
Capital House
272 Manchester Road
Droylsden
Manchester
M43 6PW
Business address
Turf Lane
Royton
Oldham
Lancashire
OL2 6EU
Bankers
Barclays Bank Plc
25 High Street
Oldham
Lancashire
OL1 3AZ
DR KERSHAW'S HOSPICE (TRADING) LIMITED
CONTENTS
Page
Directors' report
1
Accountants' report
2
Profit and loss account
3
Balance sheet
4
Notes to the financial statements
5
DR KERSHAW'S HOSPICE (TRADING) LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 MARCH 2024
- 1 -

The directors present their annual report and financial statements for the year ended 31 March 2024.

Principal activities

The principal activity of the company is that of a dormant company.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

S A Briscall
(Resigned 28 April 2023)
Dr P Cook
P Wakefield
(Resigned 20 July 2023)
J R Lipton
(Appointed 1 September 2023)
J L Wood
(Appointed 1 September 2023 and resigned 11 June 2024)
Small companies exemption

This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.

By order of the board
R Damianou
Secretary
4 October 2024
DR KERSHAW'S HOSPICE (TRADING) LIMITED
CHARTERED ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF DR KERSHAW'S HOSPICE (TRADING) LIMITED FOR THE YEAR ENDED 31 MARCH 2024
- 2 -

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Dr Kershaw's Hospice (Trading) Limited for the year ended 31 March 2024 which comprise the profit and loss account, the balance sheet and the related notes from the company’s accounting records and from information and explanations you have given us.

 

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at https://www.icaew.com/regulation.

This report is made solely to the board of directors of Dr Kershaw's Hospice (Trading) Limited, as a body, in accordance with the terms of our engagement letter dated 22 October 2021. Our work has been undertaken solely to prepare for your approval the financial statements of Dr Kershaw's Hospice (Trading) Limited and state those matters that we have agreed to state to the board of directors of Dr Kershaw's Hospice (Trading) Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Dr Kershaw's Hospice (Trading) Limited and its board of directors as a body, for our work or for this report.

It is your duty to ensure that Dr Kershaw's Hospice (Trading) Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and result of Dr Kershaw's Hospice (Trading) Limited. You consider that Dr Kershaw's Hospice (Trading) Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Dr Kershaw's Hospice (Trading) Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Chadwicks
Chartered Accountants
Capital House
272 Manchester Road
Droylsden
Manchester
M43 6PW
7 October 2024
DR KERSHAW'S HOSPICE (TRADING) LIMITED
PROFIT AND LOSS ACCOUNT
FOR THE YEAR ENDED 31 MARCH 2024
- 3 -
2024
2023
£
£
Turnover
-
1,820
Cost of sales
-
0
(1,651)
Gross profit
-
169
Administrative expenses
-
0
(170)
Operating profit/(loss)
-
(1)
Interest receivable and similar income
-
0
1
Profit before taxation
-
0
-
0
Tax on profit
-
0
-
0
Profit for the financial year
-
0
-
0
DR KERSHAW'S HOSPICE (TRADING) LIMITED
BALANCE SHEET
AS AT
31 MARCH 2024
31 March 2024
- 4 -
2024
2023
Notes
£
£
£
£
Current assets
Cash at bank and in hand
42,197
58,461
Creditors: amounts falling due within one year
2
(42,097)
(58,361)
Net current assets
100
100
Capital and reserves
Called up share capital
100
100

For the financial year ended 31 March 2024 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 4 October 2024 and are signed on its behalf by:
Dr P Cook
Director
Company registration number 05211098 (England and Wales)
DR KERSHAW'S HOSPICE (TRADING) LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024
- 5 -
1
Accounting policies
1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover comprised the value of a variety of goods sold to generate funds for Dr Kershaw's Hospice. Turnover was attributable to this activity and did not include any exports.

1.3
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.4
Company information

Dr Kershaw's Hospice (Trading) Limited is a private company limited by shares incorporated in England and Wales. The registered office is Turf Lane, Royton, Oldham, Lancashire, OL2 6EU.

2
Creditors: amounts falling due within one year
2024
2023
£
£
Amounts owed to group undertakings
41,515
57,779
Other creditors
582
582
42,097
58,361
3
Financial commitments, guarantees and contingent liabilities

The directors are not aware of any contingent liabilities.

4
Events after the reporting date

There were no significant post balance sheet events.

5
Related party transactions

The holding company is Dr Kershaw's Hospice which is a charitable company limited by guarantee. All net income generated by the company is paid to the holding company. During the year, the surplus which was payable as a charitable donation to the Hospice was £nil (2023: £nil).

2024-03-312023-04-01trueCCH SoftwareCCH Accounts Production 2024.210S A BriscallDr P CookP WakefieldJ R LiptonJ L WoodR Damianoufalsefalse052110982023-04-012024-03-3105211098bus:Director22023-04-012024-03-3105211098bus:Director42023-04-012024-03-3105211098bus:CompanySecretaryDirector12023-04-012024-03-3105211098bus:Director12023-04-012024-03-3105211098bus:Director32023-04-012024-03-3105211098bus:Director52023-04-012024-03-3105211098bus:CompanySecretary12023-04-012024-03-3105211098bus:RegisteredOffice2023-04-012024-03-3105211098bus:Agent12023-04-012024-03-31052110982024-03-31052110982022-04-012023-03-31052110982023-03-3105211098core:CurrentFinancialInstrumentscore:WithinOneYear2024-03-3105211098core:CurrentFinancialInstrumentscore:WithinOneYear2023-03-3105211098core:CurrentFinancialInstruments2024-03-3105211098core:CurrentFinancialInstruments2023-03-3105211098core:ShareCapital2024-03-3105211098core:ShareCapital2023-03-3105211098bus:EntityNoLongerTradingButTradedInPast2023-04-012024-03-3105211098bus:PrivateLimitedCompanyLtd2023-04-012024-03-3105211098bus:FRS1022023-04-012024-03-3105211098bus:AuditExemptWithAccountantsReport2023-04-012024-03-3105211098bus:FullAccounts2023-04-012024-03-31xbrli:purexbrli:sharesiso4217:GBP